Get the Stockscreener App
248.97
0.90%
2.22
After Hours:
248.97
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $248.97, with a volume of 1.19M.
It is up +0.90% in the last 24 hours and up +3.56% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$246.75
Open:
$246.7
24h Volume:
1.19M
Relative Volume:
1.52
Market Cap:
$20.84B
Revenue:
$12.71B
Net Income/Loss:
$435.50M
P/E Ratio:
48.34
EPS:
5.15
Net Cash Flow:
$843.20M
1W Performance:
+2.66%
1M Performance:
+3.56%
6M Performance:
+3.24%
1Y Performance:
+28.71%
1-Day Range:
$245.87
$249.45
1-Week Range:
$244.70
$249.45
52-Week Range:
$191.97
$258.59
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
248.97 | 20.30B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
402.82 | 148.60B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.90 | 132.07B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
513.36 | 40.34B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.92 | 30.82B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
140.33 | 23.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp Adds New Tests for Solid Tumors, Hematologic Malignancies - marketscreener.com
Labcorp Expands Oncology Portfolio to Improve Patient Care, Advance Cancer Research - marketscreener.com
Labcorp (LH) Expands Precision Oncology Portfolio with New Offerings | LH Stock News - GuruFocus
Labcorp Revolutionizes Cancer Care: New Test Portfolio Promises Faster Treatment Decisions - Stock Titan
Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report? - Yahoo Finance
Are Investors Undervaluing Labcorp (LH) Right Now? - Yahoo Finance
Labcorp Holdings Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Labcorp Holdings Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Should You Buy Labcorp Holdings Inc. (NYSE:LH) For Its Upcoming Dividend? - Yahoo
Labcorp (LH) Secures $117.03M Contract Modification for Laborato - GuruFocus
Chart of the Day: LabCorp Isn't Passing the Growth Test Yet - TheStreet Pro
Mizuho lifts LabCorp stock target to $274, keeps Outperform rating By Investing.com - Investing.com Canada
Labcorp Holdings (NYSE:LH) Partners With Frame to Enhance Fertility Testing Access - Yahoo Finance
Mizuho lifts LabCorp stock target to $274, keeps Outperform rating - Investing.com
Mizuho Adjusts Price Target on Labcorp Holdings to $274 From $264, Maintains Outperform Rating - marketscreener.com
Labcorp Holdings Inc. (LH) Announces Approval of 2025 Incentive and Stock Purchase Plans - GuruFocus
Labcorp shareholders approve new incentive plans By Investing.com - Investing.com Nigeria
Labcorp Holdings Approves Key Proposals at Annual Meeting - TipRanks
Labcorp shareholders approve new incentive plans - Investing.com
Here's Why Labcorp (LH) is a Strong Value Stock - Yahoo Finance
Baird Adjusts Price Target on Labcorp Holdings to $268 From $267, Maintains Outperform Rating - marketscreener.com
Here's Why Labcorp (LH) is a Strong Momentum Stock - Yahoo Finance
Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - GlobeNewswire Inc.
Zacks Industry Outlook Highlights Cardinal Health, Labcorp And Align Technology - Barchart.com
Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology - Yahoo Finance
Labcorp Holdings CEO Adam Schechter sells $1.52 million in stock By Investing.com - Investing.com South Africa
Labcorp Holdings CEO Adam Schechter sells $1.52 million in stock - Investing.com Australia
Insider Sell: Adam Schechter Sells Shares of Labcorp Holdings In - GuruFocus
Insider Sell: Adam Schechter Sells Shares of Labcorp Holdings Inc (LH) - GuruFocus
Labcorp Holdings Insider Sold Shares Worth $1,518,497, According to a Recent SEC Filing - marketscreener.com
LH Q1 Earnings Call: Labcorp Grows Revenue but Misses Expectations, Raises Adjusted EPS Guidance - Yahoo Finance
Labcorp Holdings (LH) Price Target Raised by Truist Securities | - GuruFocus
Labcorp (LH) Price Target Raised by Truist Analyst to $290 | LH Stock News - GuruFocus
Labcorp to Webcast Its Annual Meeting of Shareholders May 15 - The Malaysian Reserve
LabCorp Holdings Inc. (LH) Files Form 8-K with SEC - GuruFocus
Labcorp Holdings to Webcast Annual Shareholder Meeting - TipRanks
Justices' Labcorp Questions Explore Class Cert. Tensions - Law360
Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 - Yahoo Finance
Most Shareholders Will Probably Agree With Labcorp Holdings Inc.'s (NYSE:LH) CEO Compensation - simplywall.st
Labcorp Holdings' (NYSE:LH) Earnings May Just Be The Starting Point - Yahoo Finance
How A Labcorp Ruling Could Affect Wage Class Actions - Law360
Labcorp Holdings (LH) Price Target Raised by Piper Sandler | LH Stock News - GuruFocus
Analyst Expectations For Labcorp Hldgs's Future - Benzinga
Piper Sandler Adjusts Labcorp Holdings Price Target to $280 From $260, Maintains Neutral Rating - marketscreener.com
Labcorp case at Supreme Court could set precedent for class-action lawsuits - The Business Journals
Labcorp (LH) Receives Price Target Boost from Piper Sandler | LH Stock News - GuruFocus
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):